ASP Isotopes (NASDAQ:ASPI) Stock Price Up 12.1% – Time to Buy?

ASP Isotopes Inc. (NASDAQ:ASPI) shares were up 12.1% on Monday . The company traded as high as $5.96 and last traded at $6.0310. Approximately 3,404,655 shares traded hands during mid-day trading, a decline of 31% from the average daily volume of 4,923,636 shares. The stock had previously closed at $5.38.

Wall Street Analyst Weigh In

A number of analysts have commented on ASPI shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Friday, March 27th. Canaccord Genuity Group restated a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Stock Up 15.6%

The firm has a 50-day moving average of $5.04 and a two-hundred day moving average of $6.26. The stock has a market capitalization of $783.10 million, a price-to-earnings ratio of -2.91 and a beta of 3.26. The company has a quick ratio of 12.20, a current ratio of 12.23 and a debt-to-equity ratio of 0.77.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Friday, April 10th. The company reported ($0.84) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.70). The business had revenue of $33.32 million for the quarter, compared to analyst estimates of $2.03 million. ASP Isotopes had a negative return on equity of 161.55% and a negative net margin of 734.14%.

Insider Buying and Selling at ASP Isotopes

In other news, Director Duncan Moore sold 11,642 shares of the company’s stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $5.21, for a total value of $60,654.82. Following the transaction, the director directly owned 1,044,928 shares of the company’s stock, valued at approximately $5,444,074.88. This represents a 1.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Heather Kiessling sold 23,124 shares of the stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $5.48, for a total value of $126,719.52. Following the sale, the chief financial officer owned 709,376 shares of the company’s stock, valued at approximately $3,887,380.48. This represents a 3.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 90,704 shares of company stock worth $463,252. 14.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ASPI. Alyeska Investment Group L.P. increased its position in ASP Isotopes by 73.4% in the 4th quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock worth $26,191,000 after purchasing an additional 2,072,851 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of ASP Isotopes by 37.9% during the 3rd quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after buying an additional 1,241,024 shares during the last quarter. Rovida Investment Management Ltd lifted its holdings in shares of ASP Isotopes by 28.1% during the 4th quarter. Rovida Investment Management Ltd now owns 4,100,000 shares of the company’s stock valued at $21,894,000 after buying an additional 900,000 shares during the last quarter. UBS Group AG grew its stake in shares of ASP Isotopes by 150.3% in the 4th quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock valued at $12,875,000 after buying an additional 1,445,165 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of ASP Isotopes by 28.0% in the 4th quarter. Geode Capital Management LLC now owns 2,384,066 shares of the company’s stock valued at $12,758,000 after buying an additional 521,611 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.